Two Sigma Investments’s Cyclacel Pharmaceuticals CYCC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-64
| Closed | -$4.27K | – | 3184 |
|
2025
Q1 | $4.27K | Buy |
+64
| New | +$4.27K | ﹤0.01% | 3087 |
|
2023
Q4 | – | Sell |
-5
| Closed | -$5.83K | – | 3106 |
|
2023
Q3 | $5.83K | Hold |
5
| – | – | ﹤0.01% | 2834 |
|
2023
Q2 | $10.6K | Sell |
5
-1
| -17% | -$2.12K | ﹤0.01% | 2864 |
|
2023
Q1 | $12.5K | Sell |
6
-1
| -14% | -$2.09K | ﹤0.01% | 2805 |
|
2022
Q4 | $16K | Sell |
7
-12
| -63% | -$27.5K | ﹤0.01% | 2636 |
|
2022
Q3 | $98K | Buy |
+19
| New | +$98K | ﹤0.01% | 2186 |
|
2021
Q4 | – | Sell |
-8
| Closed | -$159K | – | 2685 |
|
2021
Q3 | $159K | Sell |
8
-5
| -38% | -$99.4K | ﹤0.01% | 2343 |
|
2021
Q2 | $279K | Buy |
13
+9
| +225% | +$193K | ﹤0.01% | 2149 |
|
2021
Q1 | $91K | Buy |
+4
| New | +$91K | ﹤0.01% | 2230 |
|
2018
Q1 | – | Sell |
-1
| Closed | -$122K | – | 2038 |
|
2017
Q4 | $122K | Buy |
+1
| New | +$122K | ﹤0.01% | 2077 |
|